Pharma-Bio Serv (PBSV) Net Cash Flow Growth (1y) (2011 - 2026)
Pharma-Bio Serv (PBSV) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | -43.71% |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | -2,023.91% |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | -564.99% |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | -39.60% |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | 294.02% |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | 28,500.00% |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | -128.00% |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | 175.22% |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | 24.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 24.59% |
| Jan 31, 2026 | 324.96% |
| Oct 31, 2025 | -334.52% |
| Jul 31, 2025 | -38.36% |
| Apr 30, 2025 | -82.56% |
| Jan 31, 2025 | 113.82% |
| Oct 31, 2024 | -96.73% |
| Jul 31, 2024 | 157.77% |
| Apr 30, 2024 | -446.57% |
| Jan 31, 2024 | 44.81% |
| Oct 31, 2023 | 3,008.91% |
| Jul 31, 2023 | -577.36% |
| Apr 30, 2023 | 138.00% |
| Jan 31, 2023 | -248.06% |
| Oct 31, 2022 | -75.50% |
| Jul 31, 2022 | 151.82% |
| Apr 30, 2022 | 25.04% |
| Jan 31, 2022 | -214.88% |
| Oct 31, 2021 | 196.32% |
| Jul 31, 2021 | -64.41% |